Large-Scale survey tracks Real-World results of psoriasis drug
NCT ID NCT03284879
Summary
This study aimed to understand the safety and effectiveness of the drug Otezla when used by real patients in everyday doctor's offices. It followed over 1,000 people with psoriasis or psoriatic arthritis who were starting Otezla for the first time. The goal was to collect information on side effects and how well the drug worked to control these conditions over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tugi dermatology clinic
Kitakyushu, Fukuoka, 804-0081, Japan
Conditions
Explore the condition pages connected to this study.